Refine
Department, Institute
- Fachbereich Wirtschaftswissenschaften (56)
- Fachbereich Angewandte Naturwissenschaften (27)
- Fachbereich Informatik (24)
- Institute of Visual Computing (IVC) (9)
- Fachbereich Elektrotechnik, Maschinenbau, Technikjournalismus (5)
- Institut für funktionale Gen-Analytik (IFGA) (5)
- Fachbereich Sozialpolitik und Soziale Sicherung (3)
- Institut für Sicherheitsforschung (ISF) (2)
- International Office (1)
Document Type
- Part of a Book (44)
- Article (34)
- Conference Object (19)
- Book (14)
- Bachelor Thesis (3)
- Conference Proceedings (3)
- Report (2)
- Diploma Thesis (1)
- Doctoral Thesis (1)
- Master's Thesis (1)
Year of publication
- 2007 (124) (remove)
Is part of the Bibliography
- yes (124) (remove)
Keywords
- machine vision (2)
- Adipose tissue (1)
- Anforderungsprofil (1)
- Aufsatzsammlung (1)
- Auslandsstudium (1)
- Bactericidal effect (1)
- Behindertensport (1)
- Behörde (1)
- Beruf (1)
- Bundesrepublik Deutschland (1)
- Business Intelligence (1)
- C-19 steroid (1)
- Computer (1)
- Computer science (1)
- Controlling (1)
- Corporate Governance (1)
- Corrosion inhibitors (1)
- Daptomycin (1)
- Datenanalyse (1)
- Datenbank (1)
- Diabetes (1)
- E-Business (1)
- Einkommensteuer (1)
- Electronic Commerce (1)
- Engineering (1)
- Erlebnisbericht (1)
- Fernsehmarkt (1)
- Fernsehprogramm (1)
- GC-FID (1)
- GC/MS (1)
- GC–MS (1)
- Gas chromatography-mass spectrometry (1)
- Gewerbesteuer (1)
- Glycopeptides (1)
- Hacking-Technik (1)
- Heat shrink tubing (1)
- Hibernate (1)
- Informationskosten (1)
- Informationsmanagement (1)
- Interdisziplinäre Forschung (1)
- Interkulturelle Kommunikation (1)
- Internet (1)
- Kardioprotektion (1)
- Koagulation (1)
- Kopie digitaler Daten (1)
- Körperschaftsteuer (1)
- Lehrbuch (1)
- Leistungssport (1)
- Linezolid (1)
- Lipoaspirates (1)
- Litho-Jet method (1)
- Markteffizienz (1)
- Mechanical properties of materials (1)
- Medien (1)
- Mehrachsigkeit (1)
- Mesenchymal stern cells (1)
- Multi-lineage differentiation (1)
- Musikwirtschaft (1)
- Nutzung (1)
- Online-Überwachung (1)
- Plasmodium (1)
- Politik (1)
- Polymers (1)
- Preisniveau (1)
- Primary long-chain alkyl amines (1)
- Privater Rundfunk (1)
- Programmschema (1)
- Recht (Gesetzgebung) (1)
- Regenerative medicine (1)
- Repräsentation (1)
- Resins (1)
- Schutzmaßnahme (1)
- Sicherheitslücke (1)
- Sports doping (1)
- Sportsponsoring (1)
- Stereoisomers (1)
- Synthesis (1)
- Temperaturgradienten (1)
- Time–kill methodology (1)
- Tissue engineering (1)
- Truncated dhs (1)
- Umsatzsteuer (1)
- Unternehmensbesteuerung (1)
- Werbewirkung (1)
- Werkstoffmodellierung (1)
- Wertschöpfungskette (1)
- Wirtschaftliches Verhalten (1)
- Wirtschaftstheorie (1)
- Wärmedämmschicht (1)
- automation (1)
- chemoCR (1)
- coagulation (1)
- digital storytelling (1)
- eIF-5A (1)
- economical feasibility of geothermal energy systems (1)
- edutainment (1)
- ensorless control (1)
- glimepiride (1)
- heart protection (1)
- heat shrink tubes (1)
- hypermedia (1)
- material modelling (1)
- measurement (1)
- multiaxial stress state (1)
- permanent magnet brushless dc motors (1)
- pioglitazone (1)
- postmenopause (1)
- schädliches Programm (1)
- submillimeter precision (1)
- sulfonylurea (1)
- thermal barrier coating (1)
- thermal gradient (1)
- thermo-mechanical fatigue (1)
- thermomechanische Ermüdung (1)
- thiazolidinediones (1)
- tor position (1)
- type 2 diabetes (1)
- type 2 diabetes mellitus (1)
- visual quality control (1)
- Öffentlich-rechtlicher Rundfunk (1)
Fixed-dose combination of pioglitazone and glimepiride in the treatment of Type 2 diabetes mellitus
(2007)
Type 2 diabetes is characterized by impaired insulin sensitivity and disturbances in β-cell function. While glimepiride stimulates β-cell secretion and leads to a reduction of blood glucose levels, pioglitazone activates peroxisome proliferator-activated receptor-γ and improves insulin resistance. Combining these two modes of action has been shown to improve glucose and lipid metabolism, and to improve the overall cardiovascular risk in patients with Type 2 diabetes. The combination of glimepiride and pioglitazone is generally well tolerated and a fixed combination may lead to an improved compliance in patients. The purpose of this review is to evaluate the clinical data that has been published on this combination, appearing to represent a convenient way to obtain therapeutic targets in patients with Type 2 diabetes mellitus.
Unternehmenssteuern
(2007)
Finanzierung
(2007)
Investition und Finanzierung
(2007)
Materielle Prüfung
(2007)
Wirtschaftsgut
(2007)
Konzernarten
(2007)
Formelle Prüfung
(2007)
